Clinical Trials Browser

Phase 1 × OTHER × Aprepitant × Clear all

NCT06931119 2025-04-17

Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients

Phase 1 Not yet recruiting

Pruritus

NCT00719173 2024-11-04

NRR

Phase 1 Completed

Breast Neoplasms, Nausea, Vomiting